In a small fraction (1.4% of unilateral retinoblastoma) no RB1 mutation was found, but instead an amplification of the MYCN oncogene could be detected and these tumors showed an aggressive clinical course [7]. The gene discussed is MYCN; the disease is retinoblastoma.